Back
Speaker illustration

undefined undefined undefined

Presentations

Smooth muscle cell specific ablation of CXCL12 downregulates endothelial CXCR7 leading to defective coronary arteries and cardiac hypertrophy

Event: ESC Congress 2021 - The Digital Experience

Topic: Cardiac Hypertrophy

Session: Basic science e-posters

Access
Like
Thumbnail

Loss of smooth muscle SDF-1/CXCL12 leads to cardiac hypertrophy and aortic valve stenosis

Event: ESC Congress 2020

Topic: Cardiac Diseases

Session: Cellular Pathomechanisms of Cardiac Remodeling

Access
Like
Thumbnail

Conditional ablation of SDF-1/CXCL12 in smooth muscle cells leads to severe cardiac hypertrophy and aortic valve stenosis

Event: ESC Congress 2019

Topic: Stem Cells, Cell Cycle, Cell Senescence, Cell Death

Session: Cellular cross talk in heart failure

Access
Like
Thumbnail

Smooth muscle cell specific SDF-1/CXCL12 KO mice display severe cardiac hypertrophy and vascular defects

Event: ESC Congress 2018

Topic: Cardiac Hypertrophy

Session: Signal transduction in cardiac disease

Access
Like
Thumbnail

LMNA splice variant progerin is upregulated in dilated cardiomyopathy

Event: Heart Failure 2018

Topic: Genetics, Epigenetics, ncRNA

Session: Basic Science - Cardiac Biology and Physiology

Access
Like
Thumbnail

Upregulation of the aging related LMNA splice variant progerin in cardiomyopathy

Event: ESC Congress 2017

Topic: Cardiomyopathies

Session: Cardiomyopathy

Access
Like
Thumbnail

The aging related splice variant progerin upregulated in cardiomyopathy hearts

Event: ESC Congress 2016

Topic: Premature cardiovascular ageing

Session: Premature ageing: what do we know?

Access
Like
Thumbnail

ESC 365 is supported by

novartis Explore sponsored resources